Matches in Nanopublications for { ?s ?p "[The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1244106.RAawE2FZEWYfYZ1wXmn9oyNMTTVs6LRshXdSX9VXZSIN0130_assertion description "[The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244106.RAawE2FZEWYfYZ1wXmn9oyNMTTVs6LRshXdSX9VXZSIN0130_provenance.
- NP1244107.RAMch40xOAMrTIiTYS0mAdwYnd-BSXLn92F86n6l91vvQ130_assertion description "[The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244107.RAMch40xOAMrTIiTYS0mAdwYnd-BSXLn92F86n6l91vvQ130_provenance.